Caregen
Financials
Valuation Metrics
Caregen's Market Cap is ₩1.5T. At end of 2025 it was ₩3.9T. Ranked #237 of 2,405 in KR market (top 10%), #53 of 1,627 on KOSDAQ (top 3%), #24 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 10%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 1.50T KRW | KR#237/2,405 Sec#24/231 |
| Revenue | 74.90B KRW | KR#1,579/2,405 Sec#102/231 |
| Net Income | 22.87B KRW | KR#656/2,405 Sec#43/231 |
| Total Assets | 231.27B KRW | KR#1,206/2,405 Sec#86/231 |
| Net Assets | 212.47B KRW | KR#911/2,405 Sec#64/231 |
| Employees | 193 | KR#1,123/2,405 Sec#92/231 |
| Value | ||
| P/E | 65.64x | KR#1,459/2,405 Sec#97/231 |
| P/B | 7.07x | KR#2,314/2,405 Sec#203/231 |
| P/S | 20.05x | KR#2,328/2,405 Sec#187/231 |
| EV/EBITDA | 81.83x | KR#1,469/2,405 Sec#97/231 |
| FCF Yield | 0.98% | KR#1,141/2,405 Sec#84/231 |
| Profitability | ||
| ROE | 10.77% | KR#555/2,405 Sec#37/231 |
| ROA | 9.89% | KR#278/2,405 Sec#22/231 |
| Op. Margin | 24.35% | KR#106/2,405 Sec#14/231 |
| Revenue Growth | -7.63% | KR#1,856/2,405 Sec#175/231 |
| Earnings Growth | -23.73% | KR#946/2,405 Sec#61/231 |
| Financial Health | ||
| Debt Ratio | 8.85% | KR#116/2,405 Sec#24/231 |
| Total Debt | 0 KRW | KR—/2,405 Sec—/231 |
| FCF | 14.73B KRW | KR#607/2,405 Sec#32/231 |
| Cash | 8.86B KRW | KR#1,754/2,405 Sec#155/231 |
| Current Ratio | 7.93x | KR#145/2,405 Sec#30/231 |
| Net Debt/EBITDA | -0.49x | KR#495/2,405 Sec#30/231 |
| Dividend | ||
| Div. Yield | 1.32% | KR#1,017/2,405 Sec#58/231 |
| Div. Growth | -31.72% | KR—/2,405 Sec—/231 |
| Performance | ||
| 1Y Return | -56.93% | KR#2,082/2,405 Sec#187/231 |
| 1M Return | -34.31% | KR#2,296/2,405 Sec#224/231 |
| From 52W High | -81.83% | KR#2,318/2,405 Sec#215/231 |
| 1Y MDD | -81.38% | KR#2,299/2,405 Sec#209/231 |
| Trading | ||
| Volume | 575,621 shares | KR#132/2,405 Sec#8/231 |
| Trading Value | 15.29B KRW | KR#146/2,405 Sec#7/231 |
| Foreign Own. | 4.68% | KR#914/2,405 Sec#81/231 |
| Per Share | ||
| EPS | 426 KRW | KR#1,054/2,405 Sec#75/231 |
| BPS | 3,956 KRW | KR#1,692/2,405 Sec#124/231 |
Company Info
Caregen, established in 2001 and listed on KOSDAQ in 2015, is a biotechnology company headquartered in Gangnam-gu, Seoul. It researches and develops peptides and growth factor proteins, selling professional therapy products, functional cosmetics, and health functional foods in 130 countries. The company has built a peptide library with 833 domestic and international patent registrations and is developing new drug pipelines for conditions like macular degeneration, diabetes, and hair loss. Caregen is also expanding its business into new areas such as specialized animal pharmaceuticals and functional feeds.